Generation Bio

Nasdaq:  GBIO

Filing Date:  05/22/20

Launch Date:  06/08/20

Price Range:  $16.00 - $18.00

Shares Offered (Pre-Shoe, mm):  7.4

Primary Shares (mm):  7.4

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $125.8

% Secondary:  0.0%

Shares Outstanding (mm):  41.5

Market Value at IPO Midpoint (mm):  $705.6

Offering as % of Market Value:  17.8%

Bookrunners:  J.P. Morgan | Jefferies | Cowen

Co-Manager:  Wedbush

Major Holders:  Atlas Venture Fund | Fidelity | T. Rowe Price | Invus Public Equities

Description:  Generation Bio is an innovative genetic medicines company creating a new class of gene therapy utilizing their proprietary non-viral gene therapy platform to provide durable, redosable treatments for millions of patients living with rare and prevalent diseases.

Note:  Emerging Growth Company

Reference Link:  S-1/A